Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

172

US Approved Rx

87

US Previously Marketed

67

Possibly Marketed Outside US

63

Investigational

60

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Mu opioid receptor

50

GABA-A receptor; anion channel

45

Androgen Receptor

23

Dopamine transporter

21

Kappa opioid receptor

21

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

167

Not Provided

4

Phase II

1

Phase III

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

290

1921

15

1959

8

1955

7

1937

6

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Pain

47

Insomnia

29

Anxiety

27

Unknown

23

Obesity

15

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

160

Palliative

36

Preventing

6

Curative

4

Secondary

4

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

179

CNS Penetrant

17

CNS Non-penetrant

5

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Hoffman-La Roche

11

Ciba-Geigy

6

Pfizer

6

Abbott

5

Janssen

5

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

450

Structurally Diverse

4

Mixture

3

All Match

Any Match

Exclude Selected

Exclude Selected

INN Stem

Chemical substance(-ine)

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

457

DEA NO.

455

CAS

454

PUBCHEM

453

EPA CompTox

430

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

NERVOUS SYSTEM

81

ALIMENTARY TRACT AND METABOLISM

22

RESPIRATORY SYSTEM

11

GENITO URINARY SYSTEM AND SEX HORMONES

4

SENSORY ORGANS

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

PSYCHOLEPTICS

46

ANALGESICS

20

COUGH AND COLD PREPARATIONS

10

ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS

9

ANABOLIC AGENTS FOR SYSTEMIC USE

8

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

HYPNOTICS AND SEDATIVES

29

OPIOIDS

19

ANXIOLYTICS

18

ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS

9

COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS

9

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Benzodiazepine derivatives

26

Centrally acting antiobesity products

9

Barbiturates, plain

8

Opium alkaloids and derivatives

8

Natural opium alkaloids

7

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

375

Salts, Hydrates, Esters, etc.

82

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "PART 1308 -- SCHEDULES OF CONTROLLED SUBSTANCES" in comments (approximate match)

Showing 421 - 430 of 457 results

First page
Previous page
43
Next page
Next page

Showing 421 - 430 of 457 results

First page
Previous page
43
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1